Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal



Page Path
HOME > Diabetes Metab J > Volume 24(3); 2000 > Article
Original Article The Effects of Troglitazone on Vascular Smooth Muscle Cell Proliferation.
Yun Jae Chung, Kyeong Min Min, Eun Young Oh, Jae Hoon Chung, Yong Ki Min, Myung Shik Lee, Moon Kyu Lee, Kwang Won Kim
Diabetes & Metabolism Journal 2000;24(3):348-355
Published online: January 1, 2001
  • 17 Download
  • 0 Crossref
  • 0 Scopus
1Division of Endocrinology & Metabolism, Sungkyunkwan University School of Medicine, Samsung Medical Center.
2Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center.
3Sumsung Biomedical Research Institute, Seoul, Korea.

Elevated fasting and postprandial insulin levels are frequently observed in patients with obesity and hypertension as well as type 2 diabetes mellitus. This phenomenon has been suggested as an independent risk factors for atherosclerotic cardiovascular diseases. Troglitazone, an insulin-sensitizing antidiabetic agent, has been shown to inhibit atherosclerotic process, but its mechanism of action is not yet elucidated. This study was undertaken to examine the effects of troglitazone, a peroxisome proliferator- activated receptor- (PPAR ) ligand, on vascular smooth muscle cell proliferation. METHODS: Aortic smooth muscle cells were isolated from Sprague-Dawley rats and the effects of several different agonists (insulin, ET-I, IGF-I) on cellular DNA synthesis were measured and compared with the effects of troglitazone. In addition, the mRNA of PPARgamma gene in rat aortic smooth muscle cells(RASMCs) was detected by RT-PCR methods. RESULTS:1. Insulin, endothelin-I and IGF-I significantly stimulated DNA synthesis in RASMCs (p<0.05). 2. Insulin-induced DNA synthesis was not significantly inhibited by coincubation with wortmannin or LY294002 but inhibited by PD98059. 3. Troglitazone significantly inhibited insulin, endothelin-I and IGF-I-induced DNA synthesis in RASMCs (p<0.05, respectively). 4. PPAR mRNA was detected in RASMCs by RT-PCR and its expression did not significantly increase by troglitazone treatment. CONCLUSION: Troglitazone could inhibit agonist-induced proliferation of vascular smooth muscle cells and might be a useful agent for treatment as well as prevention of atherosclerosis.

  • Cite
    export Copy
    Download Citation
    Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

    • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
    • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
    • Citation for the content below
    The Effects of Troglitazone on Vascular Smooth Muscle Cell Proliferation.
    Korean Diabetes J. 2000;24(3):348-355.   Published online January 1, 2001
Related articles
Chung YJ, Min KM, Oh EY, Chung JH, Min YK, Lee MS, Lee MK, Kim KW. The Effects of Troglitazone on Vascular Smooth Muscle Cell Proliferation.. Diabetes Metab J. 2000;24(3):348-355.

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer